Amarin Corp Plc (AMRN)

[Will Lar]

are you suggesting that Singer suggested/asked Bhatt et al to write this article?

If so, it's an interesting move indeed - let scientists comment on science, which is more convincing than the interpretation by legal staff (no offense here). With the brief pointing the legal procedural errors and the JAMA article pointing the scientific analysis errors, Amarin legal team provides the appeal court two strong arguments backed by experts in each field to reconsider the district ruling.

I assume that this article is not considered as "influencing federal judges."

Let's see how generics are making their case in their brief.